Guardian Pharmacy Services (GRDN) Liabilities and Shareholders Equity (2023 - 2026)

Guardian Pharmacy Services has reported Liabilities and Shareholders Equity for 4 years, with the latest figure at $426.9 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 27.83% year-over-year to $426.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 58.15% YoY) and the FY2025 annual result came in at $412.7 million, up 28.63% from the prior year.
• Liabilities and Shareholders Equity climbed to $426.9 million in Q1 2026 per GRDN's latest filing, from $412.7 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $426.9 million in Q1 2026 and troughed at $271.2 million in Q4 2023.
• A 4-year average of $357.5 million and a median of $352.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The widest YoY moves for Liabilities and Shareholders Equity: up 28.63% in 2025, down 12.07% in 2025.
• Over 4 years, Liabilities and Shareholders Equity stood at $271.2 million in 2023, then rose by 18.31% to $320.8 million in 2024, then climbed by 28.63% to $412.7 million in 2025, then rose by 3.46% to $426.9 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $426.9 million, $412.7 million, and $390.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.